beta

You're viewing our new website - find out more

Publication - Consultation Paper

Clinical Trial Access quality performance indicator: consultation

Published: 3 Jul 2017
Part of:
Health and social care
ISBN:
9781788510912

Consultation on the effectiveness of the Clinical Trial Access quality performance indicator (QPI) as part of the National Cancer QPIs.

20 page PDF

492.4kB

20 page PDF

492.4kB

Contents
Clinical Trial Access quality performance indicator: consultation
9. Governance and Scrutiny

20 page PDF

492.4kB

9. Governance and Scrutiny

A national and regional governance framework to assure the quality of cancer services in NHSScotland has been developed; key roles and responsibilities within this are set out below. Appendices 6 and 7 provide an overview of these governance arrangements diagrammatically. The importance of ensuring robust local governance processes are in place is recognised and it is essential that NHS Boards ensure that cancer clinical audit is fully embedded within established processes.

9.1 National

  • Scottish Cancer Taskforce
    • Accountable for overall national cancer quality programme and overseeing the quality of cancer care across NHSScotland.
    • Advising Scottish Government Health and Social Care Directorate ( SGHSCD) if escalation required.
  • Healthcare Improvement Scotland
    • Proportionate scrutiny of performance.
    • Support performance improvement.
    • Quality assurance: ensure robust action plans are in place and being progressed via regions/Boards to address any issues identified.
  • Information Services Division ( ISD)
    • Publish national comparative report on tumour specific QPIs and survival for 3 tumour types per annum and specified generic QPIs as part of the rolling programme of reporting.

9.2 Regional - Regional Cancer Networks

  • Annual regional comparative analysis and reporting against tumour specific QPIs.
  • Support national comparative reporting of specified generic QPIs.
  • Identify and share good practice.
  • In conjunction with constituent NHS Boards identify regional and local actions required to develop an action plan to address regional issues identified.
  • Review and monitoring of progress against agreed actions.
  • Provide assurance to NHS Board Chief Executive Officers and Scottish Cancer Taskforce that any issues identified have been adequately and timeously progressed.

9.3 Local - NHS Boards

  • Collect and submit data for regional comparative analysis and reporting in line with agreed measurability and reporting schedule (generic and tumour specific QPIs).
  • Utilise local governance structures to review performance, develop local action plans and monitor delivery.
  • Demonstrate continual improvements in quality of care through on-going review, analysis and feedback of clinical audit data at an individual multidisciplinary team ( MDT) or unit level.

Contact

Email: Chris Booth, chris.booth@gov.scot

Phone: 0300 244 4000 – Central Enquiry Unit

The Scottish Government
St Andrew's House
Regent Road
Edinburgh
EH1 3DG